<DOC>
	<DOCNO>NCT00647257</DOCNO>
	<brief_summary>This investigator-initial , multicenter , open-label , randomize , parallel-group comparative study evaluate effect incidence AF pacemaker dependence SSS patient receive physiological atrial-based pace alone add losartan 100mg physiological atrial-based pacing treatment . The duration study approximately 13 month , comprise 4-week pre-study period , 12-month treatment period .</brief_summary>
	<brief_title>The Effect Losartan Atrial Fibrillation ( AF ) Burden Pacemaker Dependence Patients With Sick Sinus Syndrome</brief_title>
	<detailed_description>Sick sinus syndrome common indication permanent cardiac pacing community . It result disorder impulse generation within sinus node impaired conduction impulse surround atrial tissue , thus lead clinical manifestation bradycardia . In patient SSS , AF frequently develop pacemaker implantation , progress persistent AF long term follow . The occurrence AF show independent predictor major cardiovascular event SSS patient receive physiologic pacing . Recent prospective clinical trial demonstrate physiologic pacing mode reduces risk AF compare single chamber ventricular pacing patient SSS . However , effectiveness physiologic pace reduce incidence AF patient sinus node dysfunction still incomplete . One recent clinical study report 68 % SSS patient DDDR pacemaker atrial tachyarrhythmias detect pacemaker device median 718 day follow-up . Modern pacemaker diagnostic feature permit detection storage information date , time onset , duration multiple , sequential episode atrial tachyarrhythmias . Since high percentage AF episode may asymptomatic , AF `` burden '' use surrogate end point . Prolonged P wave , shorten refractoriness , remarkably abnormal conduction disturbance presence prolong refractoriness limit effectiveness standard physiologic pace AF prevention . This could explain , least part , tendency SSS develop AF part natural history . Clinical electrophysiology focus attention electrophysiological structural property atrial muscle patient SSS : shorten inhomogeneous refractoriness local regional conduction slowing , well prolonged intra- inter-atrial conduction disturbance , well describe increase interstitial fibrosis associate genesis AF . A grow body evidence show inhibition renin-angiotensin system prevent promotion AF suppressing development atrial fibrosis structural remodeling . At present , influence treatment target aim altered fibrosis structural substrate patient SSS yet know . One strike result losartan intervention endpoint reduction hypertension ( LIFE ) study new-onset AF associate stroke significantly reduce losartan- compare atenolol-based antihypertensive treatment similar blood pressure reduction . The relative risk new-onset AF losartan group 0.67 compare atenolol group ( i.e . ; 33 % risk reduction ) Therefore , every reason believe block renin-angiotensin pathway angiotensin II type 1 receptor blockade would positive influence AF burden clinical setting . Recently , enalapril report prevent rapid atrial pacing ( 4 week ) -induced interstitial fibrosis fatty degeneration sinus node improve sinus node function canine model , support important role structural change sinus node regulation sinus node function . This possibility support therapeutic intervention use RAS inhibitor form attractive theoretical basis intervention reverse SND patient . In support hypothesis , present study undertaken determine whether selective angiotensin II type 1 receptor blockade high dose losartan effective reduce AF burden , pacemaker dependence , shorten sinus node recovery time , hsCRP , NT-pro BNP , associate cardiovascular event SSS patient receive physiologic pacing . In study , pacemaker standard rate-adaptive dual chamber pacemaker : Medtronic Kappa 900 Versa . At implantation , patient program DDI mode 50 ppm minimize ventricular pacing . All patient atrial tachyarrhythmia detection feature program `` '' pacemaker implantation . This feature provide information date , time onset , duration first 15 consecutive episode atrial tachyarrhythmia . This information retrieve follow-up visit use pacemaker programmer.Patients evaluate every 3 month pacemaker implantation . At visit , atrial tachyarrhythmia diagnostic data retrieve . Each episode classify atrial tachyarrhythmia review one investigator . False-positive detection AF due oversensing exclude use specific rule develop course previous clinical trial . On review beat-to-beat interval store diagnostic counter episode classified AF , far-field oversensing define 1 . Long interval successive detect atrial event pace short interval sense ; 2 . The difference first , third , fifth , seventh atrial interval second , fourth , sixth , eighth interval &gt; 150 beats/min ; 3 . The sum long short interatrial interval equal interatrial interval record termination episode . The atrial tachycardia detection feature Medtronic Kappa 900 Versa use AF detection study . This feature report high sensitivity specificity detection atrial tachyarrhythmias . All atrial lead bipolar . The atrial sensitivity program 0.5 mV , standard clinic protocol . The program parameter AF detection include post-ventricular atrial blanking period 150 msec , tachycardia detection rate 180 beats/min , number beat atrial tachycardia detection 200 , number beat tachycardia termination 10 , diagnostic arrhythmia counter frozen order collect information first 15 tachycardia episode . These parameter select optimize detection AF reduce likelihood nonsustained AF would fill diagnostic counter . AF episodes &lt; 1 minute duration detect episode AF . To maximize collection sequential episode AF , atrial electrogram storage feature use . In Kappa 900 Versa , electrogram retrieve first episode AF detect ( episode occurs within programmable time ) , case , electrogram review ensure appropriate classification AF . Sustained AF define atrial tachyarrhythmia atrial rate &gt; 250 beats/min duration &gt; 1 minute . The atrial rate determine base review interatrial interval store device diagnostics episode . AF burden define quantity AF document follow-up period express portion follow-up period ( hours/day ) . When event counter fill , AF burden calculate total duration AF time require fill counter . Permanent AF define AF present two consecutive visit AF burden 24 hours/day visit . CSNRT pacemaker implant visit : The correct sinus node recovery time ( CSNRT ) assess CLs 600 , 500 400 ms 30-second pacing train atrial lead . The measurement CSNRT repeat 3 time , average . Atrial-based pacemaker dependence Pacemaker dependency define absence escape intrinsic rhythm least 30 second gradual slow pace rate 30 beats/min . Pacemaker dependency examine every 3 month . Measurement Intrinsic Heart Rate Pacing system follow-up , include measurement pacing/sensing characteristic , lead impedance , surveillance battery status perform every 3 month patient . Endocardial atrial ventricular electrograms record via programmer pace mode temporarily set AAI low rate 30 beats/min . A temporary programmable function allow marker appear programmer 's electrocardiographic recording , correspond spontaneous event sense pulse generator , use measure rate intrinsic escape rhythm . Pacing rate manually step-downed 30 beats/min every 10 beats/min low pace rate , intrinsic escape rhythm check pace rate . A fixed pacing rate 30 beats/min follow gradual decrease maintain least 30 second allow emergence intrinsic escape rhythm . Approximately 220 male female patient , age 20 80 year , SSS enrol randomly assign losartan add physiological atrial-based pace physiological atrial-based pace alone treatment arm . The sample size calculate provide study 80 % power two-sided alpha level 0.05 . Assuming 33 % reduction AF incidence rate losartan group compare physiological pace group 1 year randomization . Based assumption , total sample size require estimate 100 patient arm . Thus need enroll 220 eligible case . Study medication ( losartan ) tablet form . Patients randomized losartan arm receive 50 mg day 2 week , patient up-titrated 50 mg losartan twice day follow first 2-week therapy . Each patient assess follow 4 week losartan therapy dose . If patient well tolerate dose maintain remain time study . If unable tolerate target dose permit down-titrate continue high tolerate dose . Only patient able tolerate least low dose losartan permit continue study end study period . Normotensive patient weigh less 50 kg , age 70 year receive 25 mg/day first 2 week , increase 50 mg/day , aim reach 100 mg/day rest study .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Sick Sinus Syndrome</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Patient willing sign inform consent form . Men woman ≧ 20 ≦ 80 year age . Symptomatic bradycardia &lt; 40 beats/min symptomatic QRS pause two second . Normal AV conduction ( PQ interval ≦ 220 m patients≦ 70 year PQ interval ≦ 260 m patient &gt; 70 year ) , bundle branch block ( QRS width &lt; 120 m ) Patient history know intolerance , contraindication hypersensitivity losartan . 1st , 2nd 3rd AV block Permanent therapy refractory AF Blood pressure &gt; 250/120 mmHg visit 1 . Heart Failure acc . NYHA III IV Myocardial infarction le 6 month pacemaker implant ( visit 1 ) Cerebral disease stroke less 6 month pacemaker implant ( visit 1 ) Hypertrophic obstructive cardiomyopathy Symptomatic hypo hyperthyroidism Cardiogenic shock Women pregnant lactating . Unstable angina pectoris Patients 20 year age Patients involved study Systolic pressure &lt; 100 mmHg visit 1 Reduced expectancy life due diseases Patients attend followup visit regularly Patient clinically important abnormal laboratory finding visit 1 local laboratory screen include : Serum creatinine &gt; 2.5 mg/dL ; Serum potassium &lt; 3.5 &gt; 5.7 eEq/L ; SGOT/SGPT ( ALT/AST ) &gt; 3 time upper normal limit ; Blood hemoglobin ( male &amp; female &lt; 10 g/dL )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Sick Sinus Syndrome ; Atrial Fibrillation ; Pacemaker</keyword>
</DOC>